Granules Pharmaceuticals Inc gets 5 observations from USFDA on completion of GMP inspection

Granules India Ltd that the US FDA has completed a GMP inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of the Company located in Chantilly, Virginia, USA from 11th December 2023 through 15th December 2023 with five (5) observations. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time and does not anticipate any disruptions to its business.

Shares of Granules India Limited was last trading in BSE at Rs. 388.85 as compared to the previous close of Rs. 386.45. The total number of shares traded during the day was 36379 in over 982 trades.

The stock hit an intraday high of Rs. 395.30 and intraday low of 387.40. The net turnover during the day was Rs. 14235752.00.

Source : Equity Bulls

Keywords

GranulesPharmaceuticals Subsidiary USFDA GMPInspection 5Observations